actabiomedicaActa Biomedica ScientificaActa Biomedica Scientifica2541-94202587-9596Scientific Centre for Family Health and Human Reproduction Problems10.29413/ABS.2020-5.6.6actabiomedica-2495Research ArticleВНУТРЕННИЕ БОЛЕЗНИINTERNAL DISEASESСовременное представление о кишечной микробиоте у пациентов с сахарным диабетомModern Understanding of the Gut Microbiotа in Patients with Diabetes Mellitushttps://orcid.org/0000-0002-2546-6320ЧугуноваЕ. В.ChugunovaE. V.

аспирант

664003, г. Иркутск, ул. Тимирязева, 16, Россия

Postgraduate

Timiryazeva str. 16, Irkutsk 664003, Russian Federation

e.v_chugunova@mail.ruhttps://orcid.org/0000-0003-3255-2013ДаренскаяМ. А.DarenskayaM. A.

доктор биологических наук, ведущий научный сотрудник лаборатории патофизиологии

664003, г. Иркутск, ул. Тимирязева, 16, Россия

Timiryazeva str. 16, Irkutsk 664003, Russian Federation

ФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»Scientific Centre for Family Health and Human Reproduction Problems202013012021565157Copyright © Чугунова Е.В., Даренская М.А., 20212021Чугунова Е.В., Даренская М.А.Chugunova E.V., Darenskaya M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actabiomedica.ru/jour/article/view/2495сахарный диабетмикробиота кишечникаштаммвоспалениежировая тканьdiabetes mellitusgut microbiotastraininflammationadipose tissueReferencesДедов И.И., Шестакова М.В., Майоров А.Ю. (ред.). алгоритмы специализированной медицинской помощи больным сахарным диабетом. 9-й выпуск. М.; 2019. doi: 10.14341/DM221S1Dedov II, Shestakova MV, Mayorov AYu. Algorithms of specialized medical care for patients with diabetes mellitus. 9th edition. Moscow; 2019. doi: 10.14341/DM221S1. (In Russ.)Shemyakina NA, Namokonov EV, Darenskaya MA, Kolesnikov SI, Kolesnikova LI. Advanced glycation end products and glutathione status in patients with type 2 diabetes mellitus and macroangiopathy of the lower limbs. Free Radic Biol Med. 2018; 120(S1): S60-S61. doi: 10.1016/j.freeradbiomed.2018.04.200Shemyakina NA, Namokonov EV, Darenskaya MA, Kolesnikov SI, Kolesnikova LI. Advanced glycation end products and glutathione status in patients with type 2 diabetes mellitus and macroangiopathy of the lower limbs. Free Radic Biol Med. 2018; 120(S1): S60-S61. doi: 10.1016/j.freeradbiomed.2018.04.200Kolesnikova LI, Darenskaya MA, Grebenkina LA, Gnusina SV, Kolesnikov SI. Oxidative stress in type 1 diabetes mellitus: Ethnic aspects. In: Rizwan Ahmad (ed.). Free Radicals, Antioxidants and Diseases. Rijeka: Intech Open; 2018: 65-72. doi: 10.5772/intechopen.76512Kolesnikova LI, Darenskaya MA, Grebenkina LA, Gnusina SV, Kolesnikov SI. Oxidative stress in type 1 diabetes mellitus: Ethnic aspects. In: Rizwan Ahmad (ed.). Free Radicals, Antioxidants and Diseases. Rijeka: Intech Open; 2018: 65-72. doi: 10.5772/intechopen.76512Kolesnikova LI, Darenskaya MA, Semenova NV, Grebenkina LA, Suturina LV, Dolgikh MI, et al. Lipid peroxidation and antioxidant protection in girls with type 1 diabetes mellitus during reproductive system development. Medicina. 2015; 51(2): 107-111. doi: 10.1016/j.medici.2015.01.009Kolesnikova LI, Darenskaya MA, Semenova NV, Grebenkina LA, Suturina LV, Dolgikh MI, et al. Lipid peroxidation and antioxidant protection in girls with type 1 diabetes mellitus during reproductive system development. Medicina. 2015; 51(2): 107-111. doi: 10.1016/j.medici.2015.01.009Darenskaya MA, Kolesnikov SI, Rychkova LV, Grebenkina LA, Kolesnikova LI. Oxidative stress and antioxidant defense parameters in different diseases: Ethnic aspects. Free Radic Biol Med. 2018; 120(S1): S60. doi: 10.1016/j.freeradbiomed.2018.04.199Darenskaya MA, Kolesnikov SI, Rychkova LV, Grebenkina LA, Kolesnikova LI. Oxidative stress and antioxidant defense parameters in different diseases: Ethnic aspects. Free Radic Biol Med. 2018; 120(S1): S60. doi: 10.1016/j.freeradbiomed.2018.04.199Kolesnikova LI, Kolesnikov SI, Darenskaya MA, Grebenkina LA, Semenova NV, Osipova EV, et al. Lipid status and predisposing genes in patients with diabetes mellitus type 1 from various ethnic groups. Bulletin of Experimental Biology and Medicine. 2015; 160: 278-280. doi: 10.1007/s10517-015-3149-5Kolesnikova LI, Kolesnikov SI, Darenskaya MA, Grebenkina LA, Semenova NV, Osipova EV, et al. Lipid status and predisposing genes in patients with diabetes mellitus type 1 from various ethnic groups. Bulletin of Experimental Biology and Medicine. 2015; 160: 278-280. doi: 10.1007/s10517-015-3149-5Дедов И.И., Колесникова Л.И., Бардымова Т.П., Прокофьев С.А., Иванова О.Н., Гнусина С.В. Этнические особенности сахарного диабета у народов Прибайкалья. Бюллетень СО РАМН. 2008; 28(1): 16-20.Dedov II, Kolesnikova LI, Bardymova TP, Prokofiev SA, Ivanova ON, Gnusina SV. Ethnic features of diabetes mellitus in the peoples of the Baikal region. Bulletin of the Siberian branch of the Russian Academy of Medical Sciences. 2008; 28(1): 16-20. (In Russ.)Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016; 8(1): 42. doi: 10.1186/s13073-016-0303-2Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016; 8(1): 42. doi: 10.1186/s13073-016-0303-2Galland L. The gut microbiome and the brain. J Med Food. 2014; 17(12): 1261-1272. doi: 10.1089/jmf.2014.7000Galland L. The gut microbiome and the brain. J Med Food. 2014; 17(12): 1261-1272. doi: 10.1089/jmf.2014.7000Дзгоева Ф.Х., Егшатян Л.В. Кишечная микробиота и сахарный диабет типа 2. Эндокринология: новости, мнения, обучение. 2018; 7(3): 55-63. doi: 10.24411/2304-9529-2018-13005Dzgoeva FKh, Yegshatyan LV. Intestinal microbiota and type 2 diabetes mellitus. Endocrinology: news, opinions, training. 2018; 7(3): 55-63. doi: 10.24411/2304-9529-2018-13005. (In Russ.).Siezen RJ, Kleerebezem M. The human gut microbiome: Are we our enterotypes? Microb Biotechnol. 2011; 4(5): 550-553. doi: 10.1111/j.1751-7915.2011.00290.xSiezen RJ, Kleerebezem M. The human gut microbiome: Are we our enterotypes? Microb Biotechnol. 2011; 4(5): 550-553. doi: 10.1111/j.1751-7915.2011.00290.xGiongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011; 5(1): 82-91. doi: 10.1038/ismej.2010.92Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011; 5(1): 82-91. doi: 10.1038/ismej.2010.92De Goffau MC, Fuentes S, van den Bogert B, Honkanen H, de Vos WM, Welling GW, et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014; 57(8): 1569-1577. doi: 10.1007/s00125-014-3274-0De Goffau MC, Fuentes S, van den Bogert B, Honkanen H, de Vos WM, Welling GW, et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014; 57(8): 1569-1577. doi: 10.1007/s00125-014-3274-0de Goffau MC, Luopajarvi K, Knip M, Ilonen J, Ruohtula T, Harkonen T, et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013; 62(4): 1238-1244. doi: 10.2337/db12-0526de Goffau MC, Luopajarvi K, Knip M, Ilonen J, Ruohtula T, Harkonen T, et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013; 62(4): 1238-1244. doi: 10.2337/db12-0526Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, et al. A metagenomic study of the gut microbiome in Behcet›s disease. Microbiome. 2018; 6(1): 135. doi: 10.1186/s40168-018-0520-6Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, et al. A metagenomic study of the gut microbiome in Behcet›s disease. Microbiome. 2018; 6(1): 135. doi: 10.1186/s40168-018-0520-6Zimmerman MA, Singh N, Martin PM, Thangaraju M, Ganapathy V, Waller JL, et al. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fasmediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol. 2012; 302(12): G1405-G1415. doi: 10.1152/ajpgi.00543.2011Zimmerman MA, Singh N, Martin PM, Thangaraju M, Ganapathy V, Waller JL, et al. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fasmediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol. 2012; 302(12): G1405-G1415. doi: 10.1152/ajpgi.00543.2011Gülden E, Wong FS, Wen L. The gut microbiota and type 1 diabetes. Clin Immunol. 2015; 159(2): 143-153. doi: 10.1016/j.clim.2015.05.013Gülden E, Wong FS, Wen L. The gut microbiota and type 1 diabetes. Clin Immunol. 2015; 159(2): 143-153. doi: 10.1016/j.clim.2015.05.013Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia. 2010; 53(4): 741-748. doi: 10.1007/s00125-009-1626-yLee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia. 2010; 53(4): 741-748. doi: 10.1007/s00125-009-1626-yWen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature. 2008; 455(7216): 1109-1113. doi: 10.1038/nature07336Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature. 2008; 455(7216): 1109-1113. doi: 10.1038/nature07336Mc Ardle MA, Finucane OM, Connaughton RM, McMorrow AM, Roche HM. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol. 2013; 4: 52. doi: 10.3389/fendo.2013.00052Mc Ardle MA, Finucane OM, Connaughton RM, McMorrow AM, Roche HM. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol. 2013; 4: 52. doi: 10.3389/fendo.2013.00052Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009; 9(5): 313-323. doi: 10.1038/nri2515Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009; 9(5): 313-323. doi: 10.1038/nri2515Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012; 28(5): 539-543. doi: 10.1016/j.nut.2011.08.013Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012; 28(5): 539-543. doi: 10.1016/j.nut.2011.08.013Ooi LG, Liong MT. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int J Mol Sci. 2010; 11(6): 2499-2522. doi: 10.3390/ijms11062499Ooi LG, Liong MT. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int J Mol Sci. 2010; 11(6): 2499-2522. doi: 10.3390/ijms11062499Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138: 271-281. doi: 10.1016/j.diabres.2018.02.023Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138: 271-281. doi: 10.1016/j.diabres.2018.02.023Дедов И.И., Колесникова Л.И., Бардымова Т.П., Прокофьев С.А., Иванова О.Н. Клинические, генетические и метаболические особенности сахарного диабета у больных бурятской популяции. Сахарный диабет. 2006; (3): 2-5.Dedov II, Kolesnikova LI, Bardymova TP, Prokofiev SA, Ivanova ON. Clinical, genetic and metabolic features of diabetes mellitus in patients of the Buryat population. Diabetes Mellitus. 2006; (3): 2-5. (In Russ.)Ussar S, Fujisaka S, Kahn CR. Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome. Mol Metab. 2016; 5(9): 795-803. doi: 10.1016/j.molmet.2016.07.004Ussar S, Fujisaka S, Kahn CR. Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome. Mol Metab. 2016; 5(9): 795-803. doi: 10.1016/j.molmet.2016.07.004Belkova NL, Nemchenko UM, Pogodina AV, Romanitsa AI, Novikova EA, Rychkova LV, et al. Composition and structure of gut microbiome in adolescents with obesity and different breastfeeding duration. Bulletin of Experimental Biology and Medicine. 2019; 167(6): 759-762. doi: 10.1007/s10517-019-04617-7Belkova NL, Nemchenko UM, Pogodina AV, Romanitsa AI, Novikova EA, Rychkova LV, et al. Composition and structure of gut microbiome in adolescents with obesity and different breastfeeding duration. Bulletin of Experimental Biology and Medicine. 2019; 167(6): 759-762. doi: 10.1007/s10517-019-04617-7Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013; 500: 585-588. doi: 10.1038/nature12480Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013; 500: 585-588. doi: 10.1038/nature12480Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500(7464): 541-546. doi: 10.1038/nature12506Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500(7464): 541-546. doi: 10.1038/nature12506Karlsson F, Tremaroli V, Nielsen J, Bäckhed F. Assessing the human gut microbiota in metabolic diseases. Diabetes. 2013; 62(10): 3341-3349. doi: 10.2337/db13-0844Karlsson F, Tremaroli V, Nielsen J, Bäckhed F. Assessing the human gut microbiota in metabolic diseases. Diabetes. 2013; 62(10): 3341-3349. doi: 10.2337/db13-0844Allin KH, Tremaroli V, Caesar R, Jensen BAH, Damgaard MTF, Bahl MI, et al. Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia. 2018; 61(4): 810-820. doi: 10.1007/s00125-018-4550-1Allin KH, Tremaroli V, Caesar R, Jensen BAH, Damgaard MTF, Bahl MI, et al. Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia. 2018; 61(4): 810-820. doi: 10.1007/s00125-018-4550-1Faerch K, Torekov SS, Vistisen D, Johansen NB, Witte DR, Jonsson A, et al. GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: The ADDITION-PRO study. Diabetes. 2015; 64: 2513-2525. doi: 10.2337/db14-1751Faerch K, Torekov SS, Vistisen D, Johansen NB, Witte DR, Jonsson A, et al. GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: The ADDITION-PRO study. Diabetes. 2015; 64: 2513-2525. doi: 10.2337/db14-1751Pichette J, Fynn-Sackey N, Gagnon J. Hydrogen sulfidePichette J, Fynn-Sackey N, Gagnon J. Hydrogen sulfide and sulfate prebiotic stimulates the secretion of GLP-1 and improves glycemia in male mice. Endocrinology. 2017; 158(10): 3416-3425. doi: 10.1210/en.2017-00391and sulfate prebiotic stimulates the secretion of GLP-1 and improves glycemia in male mice. Endocrinology. 2017; 158(10): 3416-3425. doi: 10.1210/en.2017-00391Wang G, Li X, Zhao J, Zhang H, Chen W. Lactobacillus casei CCFM419 attenuates type 2 diabetes via a gut microbiota dependent mechanism. Food Funct. 2017; 8(9): 3155-3164. doi: 10.1039/C7FO00593HWang G, Li X, Zhao J, Zhang H, Chen W. Lactobacillus casei CCFM419 attenuates type 2 diabetes via a gut microbiota dependent mechanism. Food Funct. 2017; 8(9): 3155-3164. doi: 10.1039/C7FO00593HMacfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int. 2012; 95(1): 50-60. doi: 10.5740/jaoacint.sge_macfarlaneMacfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int. 2012; 95(1): 50-60. doi: 10.5740/jaoacint.sge_macfarlanePuddu A, Sanguineti R, Montecucco F, Viviani GL. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflamm. 2014; 2014: 162021. doi: 10.1155/2014/162021Puddu A, Sanguineti R, Montecucco F, Viviani GL. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflamm. 2014; 2014: 162021. doi: 10.1155/2014/162021Wang S, Li Q, Zang Y, Zhao Y, Liu N, Wang Y, et al. Apple polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats. Int J Biol Macromol. 2017; 99: 282-292. doi: 10.1016/j.ijbiomac.2017.02.074Wang S, Li Q, Zang Y, Zhao Y, Liu N, Wang Y, et al. Apple polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats. Int J Biol Macromol. 2017; 99: 282-292. doi: 10.1016/j.ijbiomac.2017.02.074Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018; 359(6380): 1151-1156. doi: 10.1126/science.aao5774Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018; 359(6380): 1151-1156. doi: 10.1126/science.aao5774van der Beek CM, Canfora EE, Kip AM, Gorissen SHM, OldeDamink SWM, van Eijk HM, et al. The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men. Metabolism. 2018: 87: 25-35. doi: 10.1016/j.metabol.2018.06.009van der Beek CM, Canfora EE, Kip AM, Gorissen SHM, OldeDamink SWM, van Eijk HM, et al. The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men. Metabolism. 2018: 87: 25-35. doi: 10.1016/j.metabol.2018.06.009Torres S, Fabersani E, Marquez A, Gauffin-Cano P. Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics. Eur J Nutr. 2019; 58(1): 27-43. doi: 10.1007/s00394-018-1790-2Torres S, Fabersani E, Marquez A, Gauffin-Cano P. Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics. Eur J Nutr. 2019; 58(1): 27-43. doi: 10.1007/s00394-018-1790-2Gérard C, Brown KA. Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue. Mol Cell Endocrinol. 2018; 466: 15-30. doi: 10.1016/j.mce.2017.09.014Gérard C, Brown KA. Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue. Mol Cell Endocrinol. 2018; 466: 15-30. doi: 10.1016/j.mce.2017.09.014Lee YS, Park MS, Choung JS, Kim SS, Oh HH, Choi CS, et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia. 2012; 55(9): 2456-2468. doi: 10.1007/s00125-012-2592-3Lee YS, Park MS, Choung JS, Kim SS, Oh HH, Choi CS, et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia. 2012; 55(9): 2456-2468. doi: 10.1007/s00125-012-2592-3Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, et al. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Eur J Nutr. 2018; 57(1): 279-295. doi: 10.1007/s00394-016-1317-7Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, et al. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Eur J Nutr. 2018; 57(1): 279-295. doi: 10.1007/s00394-016-1317-7Chen LH, Chen YH, Cheng KС, Chien TY, Chan CH, Tsao SP, et al. Antiobesity effect of Lactobacillus reuteri 263 associated with energy metabolism remodeling of white adipose tissue in highenergy-diet-fed rats. J Nutr Biochem. 2018; 54: 87-94. doi: 10.1016/j.jnutbio.2017.11.004Chen LH, Chen YH, Cheng KС, Chien TY, Chan CH, Tsao SP, et al. Antiobesity effect of Lactobacillus reuteri 263 associated with energy metabolism remodeling of white adipose tissue in highenergy-diet-fed rats. J Nutr Biochem. 2018; 54: 87-94. doi: 10.1016/j.jnutbio.2017.11.004Liu J, Li Y, Yang P, Wan J, Chang Q, Wang TTY, et al. Gypenosides reduced the risk of overweight and insulin resistance in C57BL/6J mice through modulating adipose thermogenesis and gut microbiota. J Agric Food Chem. 2017; 65(42): 9237-9246. doi: 10.1021/acs.jafc.7b03382Liu J, Li Y, Yang P, Wan J, Chang Q, Wang TTY, et al. Gypenosides reduced the risk of overweight and insulin resistance in C57BL/6J mice through modulating adipose thermogenesis and gut microbiota. J Agric Food Chem. 2017; 65(42): 9237-9246. doi: 10.1021/acs.jafc.7b03382Vargas-Castillo A, Fuentes-Romero R, Rodriguez-Lopez LA, Torres N, Tovar AR. Understanding the biology of thermogenic fat: Is browning a new approach to the treatment of obesity? Arch Med Res. 2017; 48(5): 401-413. doi: 10.1016/j.arcmed.2017.10.002Vargas-Castillo A, Fuentes-Romero R, Rodriguez-Lopez LA, Torres N, Tovar AR. Understanding the biology of thermogenic fat: Is browning a new approach to the treatment of obesity? Arch Med Res. 2017; 48(5): 401-413. doi: 10.1016/j.arcmed.2017.10.002Trayhurn P. Recruiting brown adipose tissue in human obesity. Diabetes. 2016; 65(5): 1158-1160. doi: 10.2337/dbi16-0002Trayhurn P. Recruiting brown adipose tissue in human obesity. Diabetes. 2016; 65(5): 1158-1160. doi: 10.2337/dbi16-0002Trayhurn P. Brown adipose tissue – a therapeutic target in obesity? Front Physiol. 2018; 9: 1672. doi: 10.3389/fphys.2018.01672Trayhurn P. Brown adipose tissue – a therapeutic target in obesity? Front Physiol. 2018; 9: 1672. doi: 10.3389/fphys.2018.01672Choksi YA, Reddy VK, Singh K, Barrett CW, Short SP, Parang B, et al. BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunology. 2018; 11(5): 1363-1374. doi: 10.1038/s41385-018-0043-2Choksi YA, Reddy VK, Singh K, Barrett CW, Short SP, Parang B, et al. BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunology. 2018; 11(5): 1363-1374. doi: 10.1038/s41385-018-0043-2Gérard C, Vidal H. Impact of gut microbiota on host glycemic control. Front Endocrinol. 2019; 10: 29. doi: 10.3389/fendo.2019.00029Gérard C, Vidal H. Impact of gut microbiota on host glycemic control. Front Endocrinol. 2019; 10: 29. doi: 10.3389/fendo.2019.00029Brunkwall L, Orho-Melander M. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: From current human evidence to future possibilities. Diabetologia. 2017; 60(6): 943-951. doi: 10.1007/s00125-017-4278-3Brunkwall L, Orho-Melander M. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: From current human evidence to future possibilities. Diabetologia. 2017; 60(6): 943-951. doi: 10.1007/s00125-017-4278-3Mahboobi S, Rahimi F, Jafarnejad S. Effects of prebiotic and synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: A meta-analysis of randomized controlled trials. Adv Pharm Bull. 2018; 8(4): 565-574. doi: 10.15171/apb.2018.065Mahboobi S, Rahimi F, Jafarnejad S. Effects of prebiotic and synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: A meta-analysis of randomized controlled trials. Adv Pharm Bull. 2018; 8(4): 565-574. doi: 10.15171/apb.2018.065Mahboobi S, Iraj B, Maghsoudi Z, Feizi A, Ghiasvand R, Askari G, et al. The effects of probiotic supplementation on markers of blood lipids, and blood pressure in patients with prediabetes: a randomized clinical trial. Int J Prev Med. 2014; 5(10): 1239-1246.Mahboobi S, Iraj B, Maghsoudi Z, Feizi A, Ghiasvand R, Askari G, et al. The effects of probiotic supplementation on markers of blood lipids, and blood pressure in patients with prediabetes: a randomized clinical trial. Int J Prev Med. 2014; 5(10): 1239-1246.Bonder MJ, Kurilshikov A, Tigchelaar EF, Mujagic Z, Imhann F, Vila AV, et al. The effect of host genetics on the gut microbiome. Nat Gen. 2016; 48(11): 1407-1412. doi: 10.1038/ng.3663Bonder MJ, Kurilshikov A, Tigchelaar EF, Mujagic Z, Imhann F, Vila AV, et al. The effect of host genetics on the gut microbiome. Nat Gen. 2016; 48(11): 1407-1412. doi: 10.1038/ng.3663Petersen LM, Bautista EJ, Nguyen H, Hanson BM, Chen L, Lek SH, et al. Community characteristics of the gut microbiomes of competitive cyclists. Microbiome. 2017; 5: 98. doi: 10.1186/s40168-017-0320-4Petersen LM, Bautista EJ, Nguyen H, Hanson BM, Chen L, Lek SH, et al. Community characteristics of the gut microbiomes of competitive cyclists. Microbiome. 2017; 5: 98. doi: 10.1186/s40168-017-0320-4Petersen LM, Bautista EJ, Nguyen H, Hanson BM, Chen L, Lek SH, et al. Community characteristics of the gut microbiomes of competitive cyclists. Microbiome. 2017; 5: 98. doi: 10.1186/s40168-017-0320-4

The authors declare that there are no conflicts of interest present.